← back to search

Shuo Lin

Fujian Medical University ·
Area of research
Molecular Biology · Cell Biology
Research interest
Research interests include Zebrafish Biomedical Research Applications, CRISPR and Genetic Engineering, Muscle Physiology and Disorders, and Animal Genetics and Reproduction.
h-index
81
citations
26,424
works
361
NIH funding
primary concept
email

Recent publications

Efficacy and safety of theta burst versus repetitive transcranial magnetic stimulation for major depressive disorder: a meta- analysis of randomized controlled trials
Research Square 2023cited by 2position: middledoi
CRISPR/Cas9-mediated precise genome modification by a long ssDNA template in zebrafish
BMC Genomics 2020cited by 73position: middledoi
Rescue of spinal muscular atrophy mouse models with AAV9-Exon-specific U1 snRNA
Nucleic Acids Research 2019cited by 43position: middledoi
ETV2 mediates endothelial transdifferentiation of glioblastoma
Signal Transduction and Targeted Therapy 2018cited by 49position: lastdoi
Programmable base editing of zebrafish genome using a modified CRISPR-Cas9 system
Nature Communications 2017cited by 192position: lastdoi
ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13
PLoS Genetics 2017cited by 64position: lastdoi
Extracellular HSP60 triggers tissue regeneration and wound healing by regulating inflammation and cell proliferation
npj Regenerative Medicine 2016cited by 79position: middledoi
Lanthanide Hydroxide Nanoparticles Induce Angiogenesis via ROS‐Sensitive Signaling
Small 2016cited by 62position: middledoi
Organ-Specific and Size-Dependent Ag Nanoparticle Toxicity in Gills and Intestines of Adult Zebrafish
ACS Nano 2015cited by 196position: middledoi
Recurrent Mutations in the Basic Domain of TWIST2 Cause Ablepharon Macrostomia and Barber-Say Syndromes
The American Journal of Human Genetics 2015cited by 76position: middledoi
CasOT: a genome-wide Cas9/gRNA off-target searching tool
Bioinformatics 2014cited by 371position: middledoi
Aspect Ratio Plays a Role in the Hazard Potential of CeO<sub>2</sub> Nanoparticles in Mouse Lung and Zebrafish Gastrointestinal Tract
ACS Nano 2014cited by 112position: middledoi
TNF-mediated inflammation represses GATA1 and activates p38 MAP kinase in RPS19-deficient hematopoietic progenitors
Blood 2014cited by 75position: middledoi
Tcf7l2 Is Required for Left-Right Asymmetric Differentiation of Habenular Neurons
Current Biology 2014cited by 64position: middledoi
Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish
Nucleic Acids Research 2013cited by 399position: middledoi
TALEN-mediated precise genome modification by homologous recombination in zebrafish
Nature Methods 2013cited by 333position: lastdoi
Efficient Gene Targeting in Zebrafish Mediated by a Zebrafish-Codon-Optimized Cas9 and Evaluation of Off-Targeting Effect
Journal of genetics and genomics/Journal of Genetics and Genomics 2013cited by 87position: middledoi
Transdifferentiation of Fast Skeletal Muscle Into Functional Endothelium in Vivo by Transcription Factor Etv2
PLoS Biology 2013cited by 72position: lastdoi
Surface Defects on Plate-Shaped Silver Nanoparticles Contribute to Its Hazard Potential in a Fish Gill Cell Line and Zebrafish Embryos
ACS Nano 2012cited by 360position: middledoi
Zebrafish: An In Vivo Model for Nano EHS Studies
Small 2012cited by 165position: middledoi
Zebrafish High‐Throughput Screening to Study the Impact of Dissolvable Metal Oxide Nanoparticles on the Hatching Enzyme, ZHE1
Small 2012cited by 131position: middledoi
Optogenetic Control of Transcription in Zebrafish
PLoS ONE 2012cited by 89position: middledoi
Automated Phenotype Recognition for Zebrafish Embryo Based In Vivo High Throughput Toxicity Screening of Engineered Nano-Materials
PLoS ONE 2012cited by 65position: middledoi
EENdb: a database and knowledge base of ZFNs and TALENs for endonuclease engineering
Nucleic Acids Research 2012cited by 51position: middledoi
Spatiotemporal manipulation of retinoic acid activity in zebrafish hindbrain development via photo-isomerization
Development 2012cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sijie Lin · Tongji University7 papers (2012–2016)André E. Nel · California NanoSystems Institute7 papers (2012–2016)Zhaoxia Ji · Anyang Tumor Hospital5 papers (2012–2016)Tian Xia · Berkeley College5 papers (2012–2015)An Xiao · Nantong University4 papers (2012–2014)Zuoyan Zhu · Chinese Academy of Sciences4 papers (2012–2014)Haigen Huang · University of California, Los Angeles3 papers (2016–2017)Yingying Hu · Zhejiang International Studies University3 papers (2012–2013)Gustavo A. Gomez · Argerich Hospital3 papers (2012–2018)Yan Zhao · Mongolian National University of Medical Sciences3 papers (2012–2012)Chong Hyun Chang · Hainan University3 papers (2012–2015)Yao Zu · East China University of Science and Technology3 papers (2013–2013)Xiang Wang · City University of Hong Kong3 papers (2012–2015)Huan Meng · Jiangsu University3 papers (2012–2014)Zhanxiang Wang · First Affiliated Hospital of Xiamen University3 papers (2013–2013)Bo Zhang · Central South University3 papers (2013–2014)Zhipeng Yang · Harbin Medical University2 papers (2012–2013)Yingdan Wu · University of California, Los Angeles2 papers (2012–2013)Xiaochan Lu · Shandong University of Traditional Chinese Medicine2 papers (2017–2020)Haiyuan Zhang · Harbin Institute of Technology2 papers (2012–2012)